# Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine

Study · id `cardio:ct-nct04507178` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04507178](<https://clinicaltrials.gov/study/NCT04507178>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04507178

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT04507178. Randomized; single masking; primary purpose prevention. Start 2022-02-02 (actual); primary completion 2026-08-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT04507178, source copy `cardio:ctgov-nct04507178-2025-01-29`, retrieved 2026-10-31)
- Started: 2022-02-02 (actual) (ClinicalTrials.gov record NCT04507178, source copy `cardio:ctgov-nct04507178-2025-01-29`, retrieved 2026-10-31)
- Primary completion: 2026-08-01 (anticipated) (ClinicalTrials.gov record NCT04507178, source copy `cardio:ctgov-nct04507178-2025-01-29`, retrieved 2026-10-31)
- Completion: 2027-04-01 (anticipated) (ClinicalTrials.gov record NCT04507178, source copy `cardio:ctgov-nct04507178-2025-01-29`, retrieved 2026-10-31)
- Countries: Netherlands (ClinicalTrials.gov record NCT04507178, source copy `cardio:ctgov-nct04507178-2025-01-29`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04507178-2025-01-29`, retrieved 2026-10-31)

## The registry's words

- Brief title: Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine
- Acronym: ISCHEMIA
- Condition: Aneurysmal Subarachnoid Hemorrhage
- Condition: Delayed Cerebral Ischemia
- Intervention (Drug): Nadroparin Injectable Product
- Lead sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Subarachnoid hemorrhage (`cardio:subarachnoid-hemorrhage`)
- Registry lists this organization as the lead sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (`cardio:org-academisch-medisch-centrum-universiteit-van-amsterdam-amc-662d32`)

## Provenance

Content hash: a7356c2e6d9089f3a7ca9c779926d39c2218e48893df454da316885451f6eec6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
